Two Sigma Securities’s Imunon IMNN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-990
Closed -$10.3K 1688
2025
Q2
$10.3K Buy
+990
New +$13.5K ﹤0.01% 1295
2024
Q4
Sell
-807
Closed -$11.2K 2377
2024
Q3
$11.2K Buy
+807
New +$12.8K ﹤0.01% 2575
2024
Q1
Sell
-1,061
Closed -$9.41K 3258
2023
Q4
$9.41K Buy
+1,061
New +$12.9K ﹤0.01% 2826
2022
Q1
Sell
-154
Closed -$16K 2292
2021
Q4
$16K Buy
+154
New +$24K ﹤0.01% 1436
2021
Q3
Sell
-70
Closed -$17K 1725
2021
Q2
$17K Buy
+70
New +$16.5K ﹤0.01% 1453
2017
Q3
Sell
-78
Closed -$31K 1056
2017
Q2
$31K Buy
+78
New +$49.8K 0.01% 754

Other funds holding IMNN

Two Sigma Securities's IMNN Position: Q3 2025 in Review

Two Sigma Securities sold out of Imunon (IMNN) in Q3 2025, closing a stake of 990 shares — an estimated $10.3K sold.

Two Sigma Securities first reported a position in IMNN in Q2 2017 and held it in 6 quarters. The position peaked at $31K in Q2 2017. 17 funds tracked by Wall St. Rank hold IMNN as of Q3 2025.

  • Two Sigma Securities reported no remaining Imunon position as of Q3 2025 after selling out during the quarter.
  • Two Sigma Securities sold 990 Imunon shares in Q3 2025, an estimated $10.3K.
  • Two Sigma Securities first reported a position in Imunon in Q2 2017 and held it in 6 quarters.
  • Two Sigma Securities's Imunon position peaked at $31K in Q2 2017.
  • 17 funds tracked by Wall St. Rank held Imunon as of Q3 2025.

Based on Two Sigma Securities's 13F filing for Q3 2025, filed 14 Nov 2025.